These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25261238)

  • 1. Targeting cancer stem-like cells as an approach to defeating cellular heterogeneity in Ewing sarcoma.
    Cornaz-Buros S; Riggi N; DeVito C; Sarre A; Letovanec I; Provero P; Stamenkovic I
    Cancer Res; 2014 Nov; 74(22):6610-22. PubMed ID: 25261238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of cancer stem cells in Ewing's sarcoma.
    Suvà ML; Riggi N; Stehle JC; Baumer K; Tercier S; Joseph JM; Suvà D; Clément V; Provero P; Cironi L; Osterheld MC; Guillou L; Stamenkovic I
    Cancer Res; 2009 Mar; 69(5):1776-81. PubMed ID: 19208848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A TARBP2-dependent miRNA expression profile underlies cancer stem cell properties and provides candidate therapeutic reagents in Ewing sarcoma.
    De Vito C; Riggi N; Cornaz S; Suvà ML; Baumer K; Provero P; Stamenkovic I
    Cancer Cell; 2012 Jun; 21(6):807-21. PubMed ID: 22698405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photochemical internalization of CD133-targeting immunotoxins efficiently depletes sarcoma cells with stem-like properties and reduces tumorigenicity.
    Stratford EW; Bostad M; Castro R; Skarpen E; Berg K; Høgset A; Myklebost O; Selbo PK
    Biochim Biophys Acta; 2013 Aug; 1830(8):4235-43. PubMed ID: 23643966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD133 expression in chemo-resistant Ewing sarcoma cells.
    Jiang X; Gwye Y; Russell D; Cao C; Douglas D; Hung L; Kovar H; Triche TJ; Lawlor ER
    BMC Cancer; 2010 Mar; 10():116. PubMed ID: 20346143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ewing's sarcoma cancer stem cell targeted therapy.
    Todorova R
    Curr Stem Cell Res Ther; 2014 Jan; 9(1):46-62. PubMed ID: 24294922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroblastoma stem cells - mechanisms of chemoresistance and histone deacetylase inhibitors.
    Khalil MA; Hrabeta J; Cipro S; Stiborova M; Vicha A; Eckschlager T
    Neoplasma; 2012; 59(6):737-46. PubMed ID: 22862175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
    Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
    Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance of stem-like cells from neuroblastoma cell lines to commonly used chemotherapeutic agents.
    Vangipuram SD; Wang ZJ; Lyman WD
    Pediatr Blood Cancer; 2010 Mar; 54(3):361-8. PubMed ID: 19927294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma.
    Stegmaier K; Wong JS; Ross KN; Chow KT; Peck D; Wright RD; Lessnick SL; Kung AL; Golub TR
    PLoS Med; 2007 Apr; 4(4):e122. PubMed ID: 17425403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p38MAPK-Dependent sensitivity of Ewing's sarcoma family of tumors to fenretinide-induced cell death.
    Myatt SS; Redfern CP; Burchill SA
    Clin Cancer Res; 2005 Apr; 11(8):3136-48. PubMed ID: 15837770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coencapsulation of epirubicin and metformin in PEGylated liposomes inhibits the recurrence of murine sarcoma S180 existing CD133+ cancer stem-like cells.
    Yang Q; Zhang T; Wang C; Jiao J; Li J; Deng Y
    Eur J Pharm Biopharm; 2014 Nov; 88(3):737-45. PubMed ID: 25460146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.
    Zhang J; Luo N; Luo Y; Peng Z; Zhang T; Li S
    Int J Oncol; 2012 Mar; 40(3):747-56. PubMed ID: 22025269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
    Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
    Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 is of functional importance for colorectal cancer stem cells.
    Du L; Wang H; He L; Zhang J; Ni B; Wang X; Jin H; Cahuzac N; Mehrpour M; Lu Y; Chen Q
    Clin Cancer Res; 2008 Nov; 14(21):6751-60. PubMed ID: 18980968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roscovitine is an effective inducer of apoptosis of Ewing's sarcoma family tumor cells in vitro and in vivo.
    Tirado OM; Mateo-Lozano S; Notario V
    Cancer Res; 2005 Oct; 65(20):9320-7. PubMed ID: 16230394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.
    Ma S; Lee TK; Zheng BJ; Chan KW; Guan XY
    Oncogene; 2008 Mar; 27(12):1749-58. PubMed ID: 17891174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anchorage-independent growth of Ewing sarcoma cells under serum-free conditions is not associated with stem-cell like phenotype and function.
    Leuchte K; Altvater B; Hoffschlag S; Potratz J; Meltzer J; Clemens D; Luecke A; Hardes J; Dirksen U; Juergens H; Kailayangiri S; Rossig C
    Oncol Rep; 2014 Aug; 32(2):845-52. PubMed ID: 24927333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells.
    Tseng LM; Huang PI; Chen YR; Chen YC; Chou YC; Chen YW; Chang YL; Hsu HS; Lan YT; Chen KH; Chi CW; Chiou SH; Yang DM; Lee CH
    J Pharmacol Exp Ther; 2012 May; 341(2):410-23. PubMed ID: 22328572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.